These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 39335514)

  • 1. Glaucoma: Current and New Therapeutic Approaches.
    Lee HP; Tsung TH; Tsai YC; Chen YH; Lu DW
    Biomedicines; 2024 Sep; 12(9):. PubMed ID: 39335514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of the endothelin A (ET
    McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
    BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Strategies in Glaucoma.
    Gossman CA; Christie J; Webster MK; Linn DM; Linn CL
    Curr Pharm Des; 2016; 22(14):2178-92. PubMed ID: 26818878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glaucomatous optic neuropathy: Mitochondrial dynamics, dysfunction and protection in retinal ganglion cells.
    Ju WK; Perkins GA; Kim KY; Bastola T; Choi WY; Choi SH
    Prog Retin Eye Res; 2023 Jul; 95():101136. PubMed ID: 36400670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Retinal Ganglion Cell Distress in Glaucoma and Neuroprotective Potential Intervention.
    Vernazza S; Oddone F; Tirendi S; Bassi AM
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulated Cell Death of Retinal Ganglion Cells in Glaucoma: Molecular Insights and Therapeutic Potentials.
    Zhao WJ; Fan CL; Hu XM; Ban XX; Wan H; He Y; Zhang Q; Xiong K
    Cell Mol Neurobiol; 2023 Oct; 43(7):3161-3178. PubMed ID: 37338781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of potential novel glaucoma therapeutic options independent of intraocular pressure.
    Shalaby WS; Ahmed OM; Waisbourd M; Katz LJ
    Surv Ophthalmol; 2022; 67(4):1062-1080. PubMed ID: 34890600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma.
    Krishnan A; Kocab AJ; Zacks DN; Marshak-Rothstein A; Gregory-Ksander M
    J Neuroinflammation; 2019 Sep; 16(1):184. PubMed ID: 31570110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection in glaucoma: recent advances and clinical translation.
    Guymer C; Wood JP; Chidlow G; Casson RJ
    Clin Exp Ophthalmol; 2019 Jan; 47(1):88-105. PubMed ID: 29900639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational Basis for Nutraceuticals in the Treatment of Glaucoma.
    Morrone LA; Rombola L; Adornetto A; Corasaniti MT; Russo R
    Curr Neuropharmacol; 2018; 16(7):1004-1017. PubMed ID: 29119928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection for treatment of glaucoma in adults.
    Sena DF; Lindsley K
    Cochrane Database Syst Rev; 2013 Feb; 2(2):CD006539. PubMed ID: 23450569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of A-Kinase Anchoring Protein 1 in Retinal Ganglion Cells: Neurodegeneration and Neuroprotection.
    Bastola T; Perkins GA; Kim KY; Choi S; Kwon JW; Shen Z; Strack S; Ju WK
    Cells; 2023 Jun; 12(11):. PubMed ID: 37296658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the neuroprotective effects of brimonidine tartrate and melatonin on retinal ganglion cells.
    Marangoz D; Guzel E; Eyuboglu S; Gumusel A; Seckin I; Ciftci F; Yilmaz B; Yalvac I
    Int Ophthalmol; 2018 Dec; 38(6):2553-2562. PubMed ID: 29159432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glaucoma and microglia-induced neuroinflammation.
    Ishikawa M; Izumi Y; Sato K; Sato T; Zorumski CF; Kunikata H; Nakazawa T
    Front Ophthalmol (Lausanne); 2023; 3():1132011. PubMed ID: 38983051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal chelator combined with permeability enhancer ameliorates oxidative stress-associated neurodegeneration in rat eyes with elevated intraocular pressure.
    Liu P; Zhang M; Shoeb M; Hogan D; Tang L; Syed MF; Wang CZ; Campbell GA; Ansari NH
    Free Radic Biol Med; 2014 Apr; 69():289-99. PubMed ID: 24509160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of LM22A-4 by cubosomes protects retinal ganglion cells in an experimental glaucoma model.
    Ding Y; Chow SH; Chen J; Brun APL; Wu CM; Duff AP; Wang Y; Song J; Wang JH; Wong VHY; Zhao D; Nishimura T; Lee TH; Conn CE; Hsu HY; Bui BV; Liu GS; Shen HH
    Acta Biomater; 2021 May; 126():433-444. PubMed ID: 33774200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection in glaucoma - Is there a future role?
    Baltmr A; Duggan J; Nizari S; Salt TE; Cordeiro MF
    Exp Eye Res; 2010 Nov; 91(5):554-66. PubMed ID: 20800593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection in Glaucoma: Basic Aspects and Clinical Relevance.
    Kuo CY; Liu CJ
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection in glaucoma.
    Vishwaraj CR; Kavitha S; Venkatesh R; Shukla AG; Chandran P; Tripathi S
    Indian J Ophthalmol; 2022 Feb; 70(2):380-385. PubMed ID: 35086201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent Research Efforts to Achieve Neuroprotection, Progression and Treatment of Glaucoma].
    Jacobi A; van Zyl T
    Klin Monbl Augenheilkd; 2020 Feb; 237(2):133-139. PubMed ID: 32040976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.